| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.02. | Stay Powered Anywhere: Ampace Launches State-of-the-Art Portable Power Stations in Europe | 383 | PR Newswire | BERLIN, Feb. 8, 2025 /PRNewswire/ -- Ampace, a leading provider of advanced lithium-ion battery solutions, is committed to delivering green energy solutions prioritizing safety, reliability... ► Artikel lesen | |
| 08.02. | SANY Group Makes Historic Debut on the 2025 World's Top 500 Brands List | 476 | PR Newswire | SHANGHAI, Feb. 8, 2025 /PRNewswire/ -- SANY Group, a leading construction machinery manufacturer, has made history by securing the 468th position on the prestigious 2025 World's Top 500 Brands... ► Artikel lesen | |
| 08.02. | arabic.shanghai.gov.cn: Action plan 8.0 to inject more vitality into Shanghai | 375 | PR Newswire | SHANGHAI, Feb. 8, 2025 /PRNewswire/ -- A news report from arabic.shanghai.gov.cn
The latest business environment improvement action plan released in Shanghai on Feb 5 will help the... ► Artikel lesen | |
| 08.02. | russian.shanghai.gov.cn: Action plan 8.0 to inject more vitality into Shanghai | 367 | PR Newswire | SHANGHAI, Feb. 8, 2025 /PRNewswire/ -- A news report from russian.shanghai.gov.cn
The latest business environment improvement action plan released in Shanghai on Feb 5 will help... ► Artikel lesen | |
| 08.02. | german.shanghai.gov.cn: Action plan 8.0 to inject more vitality into Shanghai | 358 | PR Newswire | SHANGHAI, Feb. 8, 2025 /PRNewswire/ -- A news report from german.shanghai.gov.cn
The latest business environment improvement action plan released in Shanghai on Feb 5 will help the city... ► Artikel lesen | |
| 08.02. | BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES EXTENSION OF PRIVATE PLACEMENT CLOSING DATE | 445 | PR Newswire | // NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Feb. 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV)... ► Artikel lesen | |
| 08.02. | Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis | 536 | PR Newswire | CHENGDU, China, Feb. 8, 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 7.103 |
| NVIDIA | 5.265 |
| THYSSENKRUPP | 4.430 |
| RENK GROUP | 3.427 |
| RHEINMETALL | 3.072 |
| TUI | 2.998 |
| TESLA | 2.837 |
| PALANTIR TECHNOLOGIES | 2.683 |
| BAYER | 2.612 |
| BYD | 2.134 |
| EVOTEC | 1.973 |
| NEL | 1.951 |
| DEUTSCHE TELEKOM | 1.944 |
| DEUTSCHE BANK | 1.565 |
| COMMERZBANK | 1.467 |
| VOLKSWAGEN | 1.359 |
| XIAOMI | 1.337 |
| D-WAVE QUANTUM | 1.334 |
| NOVO NORDISK | 1.319 |
| ALIBABA | 1.204 |
| E.ON | 1.195 |
| MERCEDES-BENZ | 1.159 |
| RWE | 1.141 |
| MICROSTRATEGY | 1.118 |
| NORDEX | 1.105 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
